INTRODUCTION
Ductal carcinoma in situ (DCIS) is the most common form of early-stage breast cancer and is often detected during routine mammography. Only a small percentage (10%-30%) of cases progress to invasive ductal carcinoma (IDC), resulting in a major clinical challenge in determining which patients to treat (Allred, 2010) . The genomic and evolutionary basis of invasion remains poorly understood in DCIS due to several technical challenges in bulk tissue analysis, including the extensive intratumor heterogeneity in breast cancer (Gao et al., 2016; Shah et al., 2012; Yates et al., 2015) , the limited number of tumor cells in the ducts (Allred et al., 2008) , and the large amount of stromal cells in DCIS tumors (Virnig et al., 2010) .
Different evolutionary models have been proposed for invasion. In the independent lineage model, different initiating cells in the breast tissues give rise to the in situ and invasive subpopulations through distinct cell lineages that evolve in parallel and do not share any genomic aberrations (Sontag and Axelrod, 2005) . This model is supported by targeted studies that have shown discordant molecular markers between the in situ and invasive regions (Gerlinger et al., 2014; Miron et al., 2010; Yates et al., 2015) . In contrast, the evolutionary bottleneck model posits that a direct genomic lineage exists between the in situ cells in the ducts and the invasive cells in the adjacent tissues (Cowell et al., 2013) . This model postulates that multiple clones evolve within the ducts, after which a single clone escapes the basement membrane and expands to form the invasive tumor mass (Cowell et al., 2013 ). The bottleneck model is supported by genomic studies that report concordant mutations between the ductal and invasion regions, in addition to many invasivespecific mutations and copy number aberrations (CNAs) that are selected during invasion (Kim et al., 2015; Krøigå rd et al., 2015; Newburger et al., 2013; Yates et al., 2015) . However, precise clonal lineages have been difficult to distinguish in studies that have analyzed bulk tissue samples from DCIS patients.
Single-cell DNA sequencing methods have emerged as powerful tools for resolving intratumor heterogeneity (Navin et al., 2011; Xu et al., 2012; Zong et al., 2012) , delineating stromal cell types (Patel et al., 2014; Tirosh et al., 2016) , and detecting rare subpopulations (Aceto et al., 2014; Lohr et al., 2014; Song et al., 2017) . These methods can reconstruct evolutionary lineages in heterogeneous tumors from single-time-point samples (McPherson et al., 2016; Wang et al., 2014 ). However, a major limitation is that most single-cell isolation methods require the preparation of cell suspensions, including methods such as fluorescence-activated cell sorting (FACS) (Baslan et al., 2012; Leung et al., 2015) , micromanipulation (Grindberg et al., 2013) , microdroplets (Macosko et al., 2015) , or nanowells (Gao et al., 2017) . These procedures inherently lose all spatial information, which is critical for studies of early stage cancers-such as DCIS-where histopathology is necessary to classify tumor cells as in situ or invasive.
To address this limitation, we developed Topographical Single Cell Sequencing (TSCS) an approach that combines laser catapulting (Datta et al., 2015) and single-cell DNA sequencing to measure genomic copy number profiles of single tumor cells while preserving their spatial information in tissue sections. We hypothesized that invasive cells share a direct genomic lineage with one (or more) single cells in the ducts. To investigate this question, we applied TSCS, along with deep-exome sequencing, to trace clonal evolution during invasion in 10 high-grade frozen tumor samples from synchronous DCIS-IDC patients. Our results support a direct genomic lineage between the in situ and invasive tumor cell subpopulations and further show that most mutations and CNAs evolved within the ducts prior to invasion. These data suggest that multiple clones escaped from the ducts and co-migrated into the adjacent tissues to establish invasive carcinomas.
RESULTS

Spatially Resolved Single-Cell DNA Sequencing
To isolate single tumor cells from frozen tissue sections while preserving their spatial positions and morphology in situ, we developed TSCS. This approach combines laser-capture microdissection (LCM), laser catapulting, whole-genome amplification (WGA), and single-cell DNA sequencing ( Figure 1 and STAR Methods). First, frozen tissue sections were sectioned with a cryomicrotome and stained with H&E to identify in situ and invasive regions by histopathology. Whole-tissue imaging was performed to create a global tissue map of the tumor to identify ductal (in situ) and invasive regions prior to capture ( Figure 1A ). LCM was used to cut a circumference around each single cell with a 1-micron laser ( Figure 1B ) followed by laser catapulting to transfer the cell into collection tubes ( Figure 1C ) using a highthroughput robotic stage ( Figure 1D and STAR Methods). Laser catapulting is a touchless approach that transfers cells using UV energy, thereby mitigating bacterial contamination and adjacent cell contamination compared to standard LCM systems that require physical contact with the tissues (Vandewoestyne et al., 2013) . We optimized the UV laser parameters in normal breast tissues to minimize DNA damage from the UV laser and refined the tissue section thickness to 14 microns to mitigate the probability of cutting through individual nuclei on the cryomicrotome during tissue sectioning (STAR Methods).
Cells were isolated into lysis buffer, and WGA was performed using degenerative oligonucleotide PCR (DOP-PCR) following the single-nucleus sequencing (SNS) protocol (Gao et al., 2016; Navin et al., 2011) (Figure 1D ). Barcoded libraries were prepared, and 48-96 single cells were pooled together for multiplexed next-generation sequencing (NGS) ( Figure 1E ). After NGS, the data were demultiplexed by cell library barcode and processed to calculate genomic copy number profiles from read depth at 220 kb resolution (STAR Methods). Under these optimized parameters, TSCS generated reproducible high-resolution single-cell copy number profiles ( Figure S1 ). The spatial coordinates (x and y) were extracted from each cell and transformed in cases where multiple sections were used ( Figure 1F and STAR Methods). The single-cell genomic data were then mapped to the spatial coordinates to delineate the topographic organization of different clonal genotypes in the tissue sections ( Figure 1G ).
Cohort of Synchronous DCIS-IDC Patients
We selected a unique cohort of 10 DCIS-IDC patients with frozen tumors that had histopathologically defined regions of synchronous in situ and invasive tumor cells within the same tissue sections (Table S1 and STAR Methods). Synchronous samples provide a number of advantages over pure DCIS and recurrent IDC samples that are often collected many years apart. Longitudinal samples may be confounded by intervening therapies and differences in spatial sampling, which can lead to additional mutations that are not associated with invasion. Previous work has highlighted the utility of using synchronous DCIS-IDC samples to study invasion in breast cancer, which are matched in space and time (Hernandez et al., 2012; Johnson et al., 2012; Krøigå rd et al., 2015; Martelotto et al., 2017) . Our patient cohort consisted of 6 triple-negative (ER-, PR-, HER2-) and 4 estrogen-receptor (ER)-positive breast cancer patients (Table S1 ). Most of the patients, with the exception of P3 and P4, had high tumor grade. Importantly, the frozen tumor samples were collected prior to any therapeutic intervention. For each patient, an average of 129 single cells were sequenced to quantify genome-wide copy number. In parallel, LCM was used to isolate thousands of tumor cells from the in situ and invasive regions. Exome libraries were prepared from each region (in situ, invasive, and matched normal) and sequenced at high-coverage depth (mean = 162.8X, SEM = 18.9) to detect somatic point mutations (Table S2) . Matched normal breast tissues were sequenced in parallel at high-coverage depth (mean = 144.1X, SEM = 20.3) to identify and filter germline variants.
Copy Number Evolution during Invasion in Patient 8
We investigated copy number evolution during invasion in P8 using TSCS to profile 85 in situ cells and 150 invasive cells from tissue sections from four different tumor regions (R1-R4) (Figure 2) . SNS was performed, and genome-wide copy number profiles were calculated at 220 kb resolution (STAR Methods). We performed 1-dimensional clustering, which revealed 1 major population of diploid cells (labeled ''N'') and 3 clonal aneuploid tumor subpopulations (labeled ''A,'' ''B,'' and ''C'') ( Figure 2A ). Within each subpopulation (A, B, and C) the copy number profiles were highly correlated (A = 0.64, B = 0.71, C = 0.80, Pearson correlations), representing stable clonal expansions. Consensus profiles were calculated and compared from each tumor subpopulation and identified shared amplifications on chromosomes 2p (ALK), 8q (MYC), 14q (FOXA1), and 21q (RUNX1), in addition to many subpopulation-specific CNAs. Clone A had focal deletions in chromosomes 4p (RHOH), 9p (CDKN2A), Xq (COL4A5) and focal amplifications on chromosomes 17p (MAP2K3, NF1, and BCAS3), 12p (ALG10B and ERBB3), and Xq (AR). Clone B had deletions on chromosomes 3p (FHIT), 13 (RB1), and 8p (DBC2) and amplifications on chromosomes 2q (GALNT13), 11p (WT1), and Xp (PDK3), while clone C shared many CNA events with clone B, including an amplification on 7p (EGFR).
To delineate clonal evolution during invasion, we inferred genomic lineages and plotted the data using TimeScape (Smith et al., 2017) ( Figure 2B and STAR Methods). This analysis identified a common ancestor that evolved in the ducts with amplifications of ALK, MYC, FOXA1, and RUNX1 that subsequently diverged to form clones A and C. Clone B was a common ancestor of clone C but diverged and evolved additional CNAs in RB1, FHIT, and DBC2. These data showed that all 3 subclones evolved in the ducts from a common ancestor prior to invasion and subsequently co-migrated into the surrounding tissues, where they underwent stable clonal expansions. These data did not detect any new CNAs that were acquired in the clones during invasion, however, they did reveal a decreased frequency of subclone A (40% to 5%) in the invasive regions.
To understand the relationship between the clonal genotypes and their spatial positions, we performed multi-dimensional scaling (MDS), which identified 4 discrete clusters corresponding to different subpopulations (1 normal cell and 3 tumor subpopulations). Each subpopulation consisted of single cells that were isolated from both the in situ and invasive cells, with no clonal genotype specifically associated with the in situ or invasive regions ( Figure 2C ). MDS showed that subpopulations C and B were adjacent in high-dimensional space, while subpopulation A was the most distant.
The clonal genotypes were mapped to their spatial coordinates in the four tissue sections (R1-R4) to delineate their topography, which showed that all three tumor clones were localized to both the ductal and the invasive regions, with no single genotype mapping exclusively to one region ( Figure 2D ). However, clone A was more restricted to the ductal regions (R3), while clones B and C were more frequent in the invasive regions. Consistent with the spatial distributions, we found that clones B and C had an amplification of EGFR, which has been previously shown to be associated with cell migration (Andl et al., 2004) , while clone C had an additional deletion of FHIT, which has been shown to suppress epithelial-to-mesenchymal transition (EMT) and cell migration (Suh et al., 2014) .
Copy Number Evolution during Invasion in Patient 4
We investigated copy number evolution during invasion in P4 using TSCS to sequence 46 in situ cells and 58 invasive cells from two tumor regions (R1 and R2) (Figure 3 ). Hierarchical clustering of single-cell copy number profiles identified one subpopulation of diploid cells (N) and two aneuploid tumor subpopulations (A and B) ( Figure 3A , upper panel). Within each subpopulation, the single-cell copy number profiles showed high correlations (A = 0.89 and B = 0.60, Pearson correlations), representing stable clonal expansions. Consensus copy number profiles showed that both clones shared a common amplification of chromosome 1p (MDM4 and ABL2) in addition to many subpopulation-specific CNAs ( Figure 3A , lower panels). In clone A, we identified many focal amplifications, including chromosomes 3q (EVI1), 4p (CPEB2), 11q (CASP12), and 13q (PCDH17) and an amplification of chromosome 12q (CDK2 and MDM2). In contrast, clone B harbored many large hemizygous chromosomal deletions, including 3p (SETD2 and FHIT), 4 (FGFR3 and NEK1), 5q (PIK3R1 and APC), 14q (AKT1), 15q (NTRK3), 16q (CDH1), 17p (TP53 and MAP2K4), 18 (SMAD4), and 22 (NF2).
Clonal lineages, inferred from the major subpopulations, identified a common ancestor with an amplification of chromosome 1q that gave rise to the two tumor subpopulations in the ducts: one that had many focal amplifications of cancer genes including MDM2 and CDK2 (clone A) and another that had many large hemizygous deletions, including CDH1, TP53, FHIT, and SMAD4 (clone B) ( Figure 3C ). These data showed that genomic copy number evolution occurred within the ducts and gave rise to two major tumor subpopulations. During invasion, the frequency of clone B increased from 16% to 67%, while the frequency of clone A decreased from 84% to 33% in the invasive tissues.
MDS identified three distinct clusters that corresponded to the normal cells (N) and the two tumor clones (A and B). The MDS plot showed that each clonal genotype was composed of both in situ and invasive tumor cells, with no specific genotype associated with either region ( Figure 3B ). Next, we mapped the clonal genotypes to their spatial coordinates in the two tissue sections (R1 and R2), which showed that both clones were located in the ductal and invasive regions ( Figure 3D ). This map also showed that in region 1, most of the normal diploid cells were localized to the invasive regions, which may reflect the difficulty in distinguishing stromal from tumor cells in these regions by histopathology. Furthermore, these data showed that clone A was highly localized to the four ducts (d1-d4) in region 2, while clone B was more prevalent in the invasive regions. Consistent with the invasive spatial localization, we found that clone B had deletions in a number of cancer genes involved in cell migration, including AKT1, APC, FGFR3, CDH1, and SMAD4.
Copy Number Evolution during Invasion in the Patient
Cohort TSCS was applied to 8 additional synchronous DCIS-IDC patients to study copy number evolution during invasion. Wholetissue scanning of H&E tissue sections from each patient was performed to identify in situ and invasive regions for single-cell isolation. In total, 425 in situ and 503 invasive cells were sequenced from the 10 patients, in addition to 365 stromal diploid cells. The data were analyzed to delineate clonal substructure and copy number evolution during invasion ( Figure 4 ). Clustering of single-cell CNA profiles showed that most patients harbored 1-5 major tumor subpopulations and that these subpopulations were located in both the in situ and invasive regions ( Figure 4A ).
Four tumors (P2, P3, P7, and P9) were found to be monoclonal, while six tumors (P1, P4, P5, P6, P8, and P10) were polyclonal, harboring multiple clonal subclones in both the in situ and invasive regions (Figures 2, 3 , S2, S3, S4, and S5). Shannon diversity indexes were calculated from the single-cell CNA profiles and showed that the amount of clonal diversity did not show major changes during invasion in most patients ( Figure 4B and STAR Methods). These data showed that the amount of genomic diversity correlated with the number of subpopulations detected in the in situ or invasive regions and was inconsistent with a population bottleneck, in which a decreased in clonal diversity is expected, due to the selection of a specific clonal genotype. MDS analysis of all 10 DCIS patients identified 1-6 major clusters in each patient, including the normal cells (N) and 1-5 major tumor subpopulations (A-E) that were often separated in highdimensional space ( Figure 4C ). Moreover, the MDS plots show that within each genotype cluster, the tumor cells were localized to both the in situ and invasive regions.
Clonal lineages were inferred in the 6 polyclonal DCIS patients and plotted with TimeScape (Smith et al., 2017) (Figures 4D, S2 , S3, S4, and S5). These data showed that in all patients, the subpopulations shared a common evolutionary origin with shared truncal CNAs, suggesting that the tumors had evolved from a single cell in the duct. These data are inconsistent with an independent lineage model, in which different initiating cells give rise to the in situ and invasive subpopulations separately. In every patient, we found that the same clonal subpopulations are present in the ducts and invasive regions. However, we did observe shifts in clonal frequencies in some patients (P4, P6, and P8), suggesting that some genotypes may be more invasive than others. For example, in P4, clone B increased from 16% to 67% during invasion, while in P6, clone C increased from 19% to 49%. These data suggest that genome evolution initiated from a single cell in the ducts and gave rise to one or more clonal subpopulations that migrated into the adjacent tissues to establish the invasive tumor mass.
Mapping of Spatial Topography and Clonal Genotypes
To understand the distribution of clonal genotypes and their spatial organization in the polyclonal tumors, we constructed tanglegrams (Scornavacca et al., 2011) . Genetic distance trees were calculated from single-cell copy number profiles and mapped to spatial trees (x and y coordinates) with minimal overlapping connections ( Figure 5 and STAR Methods). In P4, clone A (81.5%) localized mainly to the ducts, with only a few cells (n = 7) in the invasive regions, while clone B showed a higher frequency in the invasive regions. In P5, the two major clones (A and B) mapped to all three ducts and the invasive regions; however, clone B was restricted more to d2 and d3. In P6, we identified 5 clonal subpopulations in which clones A, B, and C mapped more frequently to the invasive regions, while clones D and E were found mainly in the ductal regions (d1, d2, and d5). In P8, we identified 3 clonal subpopulations in which clones B and C each mapped to 8 of the 10 ducts, while clone A was localized mainly to two ducts (d1 and d2). In other cases (P10 and P1) we found that the clones were equally distributed to the in situ and invasive regions. These data show that while all clones were detected in both the in situ and invasive regions, specific subclones were more restricted to the ducts, while others were more prevalent in the invasive regions, suggesting that they may have had a more invasive or migratory phenotype.
Mutational Evolution during Invasion
To investigate mutational evolution during invasion, we performed LCM to microdissect thousands of tumor cells from the in situ and invasive regions for deep-exome sequencing (mean = 162.8X, SEM = 18.9; Figure 6 ). Matched normal breast tissue (mean = 144.1X, SEM = 20.3) was sequenced in parallel to distinguish germline variants from somatic mutations. From these data, we detected point mutations, which showed that the total number of exonic mutations (mean = 23, SEM = 3.3) were highly consistent between the in situ and invasive regions (t test, p = 0.868) ( Figure 6A ). To identify specific mutations that were discordant, we constructed oncomaps using nonsynonymous mutations ( Figure 6B ). Most nonsynonymous mutations (mean 87.4%), including mutations in known breast cancer genes such as TP53, PIK3CA, NCOA2, ABL2, PDE4DIP, AHNAK and RUNX1, were concordant in the ducts and invasive regions, suggesting that they were acquired in the ducts prior to invasion. However, a few mutations were in situ specific (n = 12) or invasive specific (n = 11) in 4 patients (P3, P4, P7, and P8) and were not recurrent among the patients (Table S3 ).
The invasive-specific mutations may have occurred at low frequencies in the ducts prior to invasion (below the exome sensitivity) or, alternatively, after invasion during the expansion of the invasive tumor mass. Another possibility is that they were sampled from different geographical regions; however, this is unlikely in synchronous DCIS-IDC tissue because the cells were collected from adjacent regions in the same tissue sections. To determine if the invasive-specific mutations were acquired in the ducts or after invasion, we performed targeted deep-amplicon sequencing at high-coverage depth (mean = 453,446X) for a subset of the in situ-specific ( Figure 6C ) and invasive-specific mutations ( Figure 6D ). In parallel, we performed targeted deep-amplicon sequencing of matched normal breast tissues to establish site-specific background error rates and identified significant mutations using deepSNV (Gerstung et al., 2014) .
The amplicon data showed that at higher-coverage depth many of the in situ-specific mutations were present at low frequencies in the invasive regions. In contrast, most of the invasive-specific mutations (8 of 12) were found to be exclusive to the invasive tissues in P3 (DRD1 and CRY1), P4 (TECRL), P7 (SCNA4 and PCDHA5), and P8 (SORBS2, LAMTOR1, and AKAP6) at higher-coverage depths (Table S5) . These mutations are unlikely to play an important role in invasion since they were acquired after the tumor cells escaped the basement membrane during the expansion of the invasive carcinoma. However, in one patient (P8), we identified a few mutations (NCOA2, MMP8, RNF182, and LTBP2) that were pre-existing at low frequencies and increased in frequency during invasion (Table S4 ). These mutations included MMP8, which is a matrix metallopeptidase that plays a role in breaking down the extracellular matrix (Sarper et al., 2017) , and LTBP2, which interacts with TGF-beta and regulates cell adhesion (Vehvilä inen et al., 2003) .
We further investigated whether any of the concordant mutations showed large changes in mutation frequencies by constructing tumor-purity normalized line plots (Figure 7 ). This analysis showed that there were only minor changes in mutation frequencies during invasion in five patients ( Figure 7A ), while the other five patients had at least one mutation with a large (>0.5) frequency change ( Figure 7B ). From these data, 7 mutations-including MEGF9 in P1 (19% to 100%), NPY4R in P3 (48% to 100%), AHDC1 in P5 (33% to 100%) and 4 mutations in P8-were identified that underwent large (>0.5) mutation-frequency changes during invasion (Table S4) . However, most patients (P1, P3, and P5) had only a single concordant mutation that underwent a large frequency shift during invasion, with the exception of P8.
To infer clonal dynamics during invasion, we applied PyClone 2 (Roth et al., 2014) and clonality inference in tumors using phylogeny (CITUP) (Malikic et al., 2015) to cluster mutation frequencies and estimated clonal subpopulations after purity and copy number normalization (Figure 7 ). This analysis identified 2-5 major subpopulations in each patient, which was higher than the number of subpopulations detected by single cell copy number profiling. Several tumors that were found to be monoclonal by single cell copy number profiling (P2, P3, P7, and P9) showed 2-5 subpopulations based on the inferred mutation clusters. These data suggest that there was ongoing mutational evolution in the ducts after copy number evolution, leading to further subclonal diversification that occurred prior to invasion into the adjacent tissues. While some of the clonal frequencies shifted during invasion ( Figure 7B ), the total number of subpopulations estimated from exome mutations remained consistent in most patients.
DISCUSSION
In this study, we developed a spatially resolved single-cell DNAsequencing method and applied it to study genome evolution during invasion in 10 early-stage breast cancer patients. Our study reports three important findings. First, we show that genome evolution occurs within the ducts, before the tumor cells escape the basement membrane. Second, our data suggest that all subclones in the ducts arise from a single initiating cell, as evidenced by many shared truncal mutations and CNAs. Third, our data show that one or more clones co-migrated through the basement membrane into the adjacent tissues to establish the invasive tumor mass. We refer to this model as ''multiclonal invasion'' to distinguish it from the evolutionary bottleneck or independent lineage models that have previously been proposed for invasion in DCIS ( Figure S6) . Consistent with our model, a study using flow sorting and single-cell copy number profiling in a single DCIS patient also reported evidence that multiple clones crossed the basement membrane (Martelotto et al., 2017) .
Our model contrasts with previous work that has posited that genomic evolution during invasion occurs via a population bottleneck (Hernandez et al., 2012; Heselmeyer-Haddad et al., 2012; Sakr et al., 2014) or through independent cell lineages (Foschini et al., 2013) . In our data, we show that the same subclones were present in both the in situ and invasive regions in all 10 patients, with no additional CNA events that were acquired during invasion and few invasive-specific mutations. These data suggest that a single clone was not selected during invasion through an evolutionary bottleneck. Furthermore, our data do not support an independent lineage model (Miron et al., 2010; Sontag and Axelrod, 2005) because we identified a large number of shared truncal mutations and CNAs in all tumor cells, suggesting that a field effect did not give rise to two different clones that formed the in situ and invasive regions independently.
The total number of clonal subpopulations we identified is similar to previous reports in invasive ductal carcinomas (Gao et al., 2016; Navin et al., 2010; Shah et al., 2012; Yates et al., 2015) and is consistent with a punctuated model of copy number evolution, in which short bursts of genome instability give rise to multiple clones that stably expand to form the tumor mass (Gao et al., 2016; Navin et al., 2011) . However, previous studies could not resolve whether the punctuated bursts of genomic instability occurred within the ducts or during the expansion of the invasive tumor mass, the former of which our data strongly support. Although the mechanisms of punctuated copy number evolution remain unknown, we speculate that telomere crisis (Chin et al., 2004 ) is a plausible model. Interestingly, our data also show that most somatic mutations, including driver mutations in TP53 and PIK3CA, were acquired in the ducts prior to invasion at the earliest stages of tumor progression.
The co-migration of multiple clones into the invasive regions raises interesting questions, by suggesting that invasion occurs either through (1) the complete breakdown of the basement membrane and random escape of tumor clones into the adjacent tissues or (2) the cooperation of tumor clones that collectively break down the basement membrane. The latter may occur through mutualistic interactions between tumor clones or through commensalism, in which a single leader clone breaks through the basement membrane and clears the path for subsequent follower clones to escape. Understanding these clonal interactions during invasion will require further functional studies using in vivo systems.
This study has a few notable limitations. First, the cohort size was limited to 10 patients, and thus, we cannot exclude the possibility that some early breast cancer patients follow alternative evolutionary models, particularly in low-grade tumors. Second, we profiled a limited number of cells in each patient, which may lead to sampling bias. To investigate this question, we calculated posterior saturation curves (Gao et al., 2016) , which suggest that we sampled sufficient cells to detect the major tumor subpopulations in most patients ( Figure S7 ). Third, our study did not investigate epigenetic modifications or stromal cell types, the latter of which may also modulate the ability of the tumor cells to invade the surrounding tissues (Hu et al., 2008; Sharma et al., 2010). These represent important future directions that can be addressed with single-cell RNA and epigenomic profiling methods.
TSCS and other spatially resolved single-cell sequencing methods hold great potential for opening up new avenues of investigation in early-stage cancers. Of particular interest will be the analysis of tumor initiation and invasion in early-stage cancers with well-defined histopathologies, such as colorectal adenomas, lobular carcinoma in situ (LCIS), prostatic intraepithelial neoplasias (PIN), and pancreatic intraepithelial neoplasias (PanINs). In these cancers, spatial resolution can provide new insights into the context, organization, and migration of tumor clones as they escape the basement membranes and invade the surrounding tissues. These studies will begin to shed light onto the enigmatic question of why some premalignant cancers remain indolent for the lifetime of the patient while others progress to invasive disease and ultimately cause morbidity in patients.
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CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Dr. Nicholas E. Navin (nnavin@mdanderson.org).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Ten frozen synchronous DCIS-IDC tissue from women with paired normal adjacent breast tissues were obtained from the UT MD Anderson Cancer Center Breast Tissue Bank. The patient ages ranged from 36-77 years and is indicated in Table S1 . Frozen tissues were selected based on the presence of both in situ and invasive legions, or classification as synchronous DCIS-IDC and availability of paired normal adjacent breast tissues. ER and PR status of < 1% was determined by IHC; while, HER2 status was defined through FISH analysis using a CEP-17 centromere control probe (ratio of Her2/CEP17 < 2.2) and were scored separately for the in situ and invasive regions. Six of the ten samples were classified as triple-negative based on negative staining for ER, PR and HER2. Receptor status and clinical parameters such as age, stage, grade, and number of cell collected per region are provided in Table S1 . The study was approved by the IRB at the MD Anderson Cancer Center.
METHOD DETAILS Frozen Tissue Section Staining
Frozen tumors were divided into 1-2mm tissue blocks and mounted on OCT Compound (Tissue-Tek, Cat# 25608-930) without embedding the tissue that was used for sectioning. Mounted tumor tissue was sectioned using Thermo Scientific CryoStar (NX70) or Leica Cryostat (cm3050S) at À23 C to À27 C. Sections 12 and 14 mm thick were placed on untreated PEN-membrane slides (Carl Zeiss Microscopy, Cat# 415190-9041-001) . Standard procedures for Harris and Eosin Y (VWR Cat#588X-75) staining were used for staining. Tissue sections were scanned using the AxioCam iCC 1 on the PALM MicroBeam at 10x magnification prior to collection.
Single Cell Isolation by Laser-Catapulting
Single cells were identified in the in situ and invasive regions of the tissue sections and selected by histology (size, shape, location to nearest duct). PALM Robo wizard (Carl Zeiss) was used to optimize the UV cutting parameters. The optimal energy for laser-catapulting single cells was set between 20-25 delta in order to reduce DNA fragmentation and increase collection efficiency. Delta settings below 15 resulted infrequent cell transfer failures by laser catapulting. Brightfield images were collected before and after capture of each single cell, along with parameters used for UV cutting and catapulting.
Single Cell Whole Genome Amplification Single cells were laser-catapulted into 8-strips of 0.2 mL PCR tube caps containing 10 mL of lysis solution from Sigma-Aldrich GenomePlex WGA4 kit (cat# WGA4-50RXN) in a 96-cell manifold with robotic automation. After capture, the cells and lysis buffer were spun down at 12,000 rpm. Single cell DNA was amplified using Degenerative-Oligonucleotide-Primer PCR (DOP-PCR) following the Single Nucleus Sequencing (SNS) protocol as previously described (Baslan et al., 2012; Navin et al., 2011) . For quality control (QC), WGA DNA size distributions were determined through electrophoresis and only samples with fragment sizes > 300bp were selected and purified . Purified WGA DNA was measured on a Qubit 2.0 Fluorometer (Fisher Cat#Q32854) and samples containing > 200ng of DNA were selected for library construction and next-generation sequencing.
Single Cell Barcoded Library Construction
Single cell amplified DOP-PCR products that passed QC were sonicated to 250bp using the S220 acoustic sonicator (Covaris). Following sonication, TA-ligation based Illumina libraries were prepared as previously described (Gao et al., 2016) . Alterations to this protocol included increased ligation time at 20 C for 30 minutes and PCR amplification cycles were adjusted according to input DNA (8 cycles for 1ug, 9 cycles for 500ng, and 10 cycles for 200ng). The insert size distributions of pooled multiplexed libraries were measured using the Bioanalyzer 2100 or Tape Station (Agilent). Multiplexed libraries were sequenced for 76 cycles using single-end or paired-end flow cells lanes on the HiSeq2000 or HiSeq4000 systems (Illumina).
Bulk Frozen Tissue Microdissection
Frozen tissue sections were fixed and H&E stained as described above. Whole-tissue sections on slides were scanned and marked as in situ, invasive, or stroma. Tissue was collected using a Laser-Capture-Microdissection (LCM) on the PALM System (Carl Zeiss). The pathologist reviewed adjacent 6 mm H&E stained tissue sections to verify the in situ and invasive regions prior to LCM. Tissue regions containing thousands of cells were cut by a UV laser (settings of 72-81 delta) and catapulted (setting of 50-100 delta) into 0.2 mL adhesive PCR tube caps (Item #: Zeiss 415190-9181-000 or 415190-9191-000). DNA was isolated using the QIAamp DNA Micro Kit (QIAGEN Cat# 56304) according to manufacturer's instructions, with one modification: the samples were incubated at 56 C overnight. DNA concentration was measured on Qubit 2.0. Fresh frozen adjacent normal tissue was also processed in parallel; DNA was isolated using the DNeasy Blood & Tissue Kit (QIAGEN Cat# 69506). DNA concentrations were quantified by Qubit 2.0. Normal DNA was isolated using the QIAGEN DNeasy protocol (Cat # 69506).
Exome Library Construction and Sequencing
Exome libraries were constructed from DNA isolated by LCM from in situ and invasive regions, in addition to matched normal tissues. DNA was fragmented to 250 bp using the Covaris Sonicator and purified by Zymo DNA Clean & Concentrator Column Kit (Genesee Cat # 11-303 or 11-306) according to manufacturer's instructions. Barcoded next-generation sequencing libraries were constructed using the NEBNext end repair (NEB, E6050L), dA-tailing module (NEB, E6053L) and quick ligation module (NEB, E6056L). Libraries were PCR amplified with NEBNext HiFi 2x PCRmix (NEB, M0541L). Capture reactions were quantified using Qubit 2.0 Fluorometer and measured by quantitative PCR using the KAPA Library Quantification Kit (KAPA Biosystems, KK4835). Exome captures were performed using Nimblegen's SeqCap EZ Exome V2 kit (Roche, 05860482001) and sequenced on a 100 paired-end flowcell on the Illumina HiSeq4000 system.
QUANTIFICATION AND STATISTICAL ANALYSIS
Single Cell Copy Number Calculations Multiplexed single-cell FASTQ files corresponding to the single cell samples were deconvoluted using 1 mismatch of the 6-8pb barcodes. The deconvoluted FASTQ files were aligned to hg19 (NCBS build 36) using Bowtie 2 (2.1.0) alignment software. The aligned reads were converted from SAM files to BAM files, then sorted using SAMtools (0.1.16). PCR duplicates were marked and removed using SAMtools. The sequencing data was processed following the 'variable binning' pipeline (Baslan et al., 2012; Baslan et al., 2015) . Briefly, reads were aligned to the human genome HG19 using Bowtie2 and counted in variable bins at a genomic resolution of 220kb. Unique normalized read counts were segmented using the circular binary segmentation (CBS) method from R Bioconductor 'DNAcopy' package (Shah et al., 2006) followed by MergeLevels to join adjacent segments with non-significant differences in segmented ratios. The parameters used for CBS segmentation were alpha = 0.0001 and undo.prune = 0.05. Default parameters were used for MergeLevels, which removed erroneous chromosome breakpoints. Data was filtering with more than 100 break points or identified as noise with the R package for Density-based spatial clustering of applications (Dudik et al., 2015; Ester et al., 1996; Yue et al., 2004) with noise 'dbscan' (v1.1-1) (Piekenbrock, 2017) . We used this package to determine technical noise within the copy number profiles. We examined the plots to find the elbow and recorded this value for selecting the eps to filter data using the 'dbscan' package. Using this number, dbscan determined which single cell samples exhibited to much technical noise and filtered approximately 20% of the total datasets for each patient.
Identification of Subclones from CNA Data
The optimal 'k' (number of clusters between 1-15) was determined using the R-package 'cluster', clusGap function (K.max = 15, B = 100, FUNcluster = kmeans). The maxSE (method = ''firstSEmax'') was used to select the best number of clusters using k-means clustering. The original method (Maechler et al., 2012) used the location of the first f() values which is less than or equal to the first local maximum minus the standard error factor times the standard error function and within the range of the function of standard error maximum 1 SE (Tibshirani et al., 2001) . After this, a k-means matrix was calculated using 250 original start sites for k+1. The matrix was sampled by start sites. We used ward.D2 clustering to generate the genetic trees based on the k-means matrix. The tree was cut into k clusters to determine the number of clones. The internal Pearson and Spearman correlation of the samples within each cluster was calculated. Most of cells with technical noise were removed in the previous filtering steps, however in a few cases, we identified additional cells with an internal correlation of Pearson and Spearman of less than 0.2, which were excluded from further analysis.
Multi-dimensional-Scaling Analysis MDS plots were constructed in R using the single cell genotype binary matrix with columns as single cells and rows as mutations. Multidimensional Scaling was performed using the following command: cmdscale(x, eig = TRUE, k = 2).
Calculation of the Subclonal Diversity Index
To calculate the subpopulation diversity index for each tumor, we performed hierarchical clustering of copy number data to cluster the aneuploid tumor cells into 1-5 major groups ('species') based on Euclidean distances. From this grouping we calculated the proportion (p) of cells that belong to each distinct group. The subpopulation diversity index is then calculated as Shannon Index:
, where larger values representing higher subclonal diversity within the tumor.
Spatial Image Data Processing
The spatial coordinates (x and y) of each cell from the LCM tissue maps were extracted from the elements in the whole tissue scan at 10X magnification from each tissue section. Since multiple tissue sections were often used for collection we estimated the Z axis by sequential sections that were cut at 12-14 microns. In cases where tissue sections had different orientations, we rotated the spatial coordinates and transposed the coordinate values. We also collected brightfield images at 63X magnification before and after lasercatapulting, to confirm that single cells were isolated without adjacent material from neighboring cells. Additionally, these images were used to validate that the individual cells were collected from in situ and invasive regions, or stroma. Following the genomic analysis of clonal subpopulations, single cells were colored by clonal genotypes in the whole-tissue scanned images, in addition to ducts that were false-colored and enumerated.
Mapping Spatial Coordinates and Genomic Data
Spatial trees were constructed using Euclidean distance between cell coordinates and clustered with the hclust function using ''ward.D2'' linkage in R. Cells of the same tumor from different sample vials were given an artificial distance to buffer samples in which the distance between the regions of the tissue sections was unknown. The genetic trees from copy number profiles were constructed as described above. The genetic and spatial trees were mapped using Tanglegram version 1.5.2 of the dendextend package in R. Tanglegrams were untangled to minimize artificial branch crossing by first testing 100 random shuffles then by local stepwise untangling.
Exome Data Processing and Analysis
Sequence reads in FASTQ files corresponding to the regional and normal samples were aligned to the hg19 using the Bowtie 2 alignment software. Samtools (0.1.16) converted SAM files to compressed BAM files and sorted BAM files by coordinate. Duplicate PCR reads were removed with Picard. GATK was used to detect variants and generate a multi-cell VCF file. GATK was also used to recalibrate variant quality scores. We ran GATK with default parameters for depth (maximum read coverage = 250x). Germline SNPs were filtered out that were identified in the matched normal tissue samples. Mutations with less than 20X depth or less than 5 variant reads were filtered from the VCF4 file. Variant annotation was performed on the VCF4 file using ANNOVAR (Wang et al., 2010) . Cancer genes were annotated using the 413 genes compiled from multiple databases including the Cancer Gene Census (Futreal et al., 2004) , The Cancer Gene Atlas Project (TCGA), and the NCI cancer gene index (Sophic Systems Alliance, Biomax Informatics A.G) used in previous publications (Gao et al., 2016; Wang et al., 2014) .
Targeted Deep Sequencing of PCR Amplicons
The invasive specific mutations were validated by targeted deep-amplicon sequencing. The primers were designed using Primer 3 (bioinfo.ut.ee/primer3-0.4.0/), with five base pairs upstream and downstream of the SNP location used as a target. The amplicon size range was limited to 100-225bp (Table S6) . DNA isolated by LCM from invasive or in situ regions was used for PCR. The amplicons from different regions were pooled in equimolar amounts and sequencing libraries were constructed using NEBNext DNA library Prep enzymes (NEB, #E6050L, E6053L, E6056L/M0202L, and M0541 for end-repair, 3 0 adenylation, ligation and PCR amplification) according to manufacturer's instructions. Following ligation, DNA underwent a negative and positive selection with Ampure XP beads (Beckman Coulter, #A63881), 0.7 3 and 0.15 3 respectively, prior to PCR amplification. Final library concentrations were measured using the Qubit 2.0 Fluorometer. Samples were diluted to 10nM and then sequenced on the MiSeq system (Illumina, 150 paired-end) to obtain a target coverage depth of > 100,000X.
Detection of Rare Mutations in Amplicon Data
Statistical significance of observed variants was calculated using deepSNV version 1.16.0, which detects variants assuming a betabinomial model (Gerstung et al., 2012) . To estimate the over dispersion parameter of the model, data from the targeted sites plus flanking regions of 20bp on either side were used. DeepSNV was used to calculate p values for the null hypothesis that the targeted variant was equally frequent in primary tumor and control using separate one-tailed likelihood ratio tests for each strand orientation, and combining the p values using Fisher's method.
Saturation Analysis to Estimate Cell Numbers
To estimate whether we sequenced sufficient numbers of cells to discover the major tumor subpopulations in both in situ and invasive regions, we performed a post hoc saturation analysis as previously described (Gao et al., 2016) . We defined the total number of subpopulations and the fractions of each subpopulation in both the in situ and invasive regions using the experimental single cell copy number data for each patient. We then calculated the accumulative multinomial distribution probability of observing at least 2 tumor cells in each subpopulation, given the numbers of cells sequenced in our experiments. Since we only consider the tumor cells subpopulations, we did not restrict the number of normal cells to be observed. The same calculations were performed for both the in situ and invasive regions and then pooled together with weighted averages using the post hoc fractions to obtain the total number of cells per patient. Only one monoclonal tumor, MP7 was excluded from this analysis since there was only a single clone detected with no normal diploid cells.
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